Digital Prosthetics + Exercise for Diabetic Amputation
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new digital prosthetic technology, Digital Prosthetic Interface Technology, combined with an exercise program to assist individuals who have lost a lower leg due to complications from type 2 diabetes. It tests whether this technology can enhance participants' health and mobility compared to traditional prosthetics. Participants will either use the new digital prosthetic or continue with their usual prosthetic setup. The trial seeks individuals with a single lower-leg amputation from diabetes, who have used a prosthesis for at least two months and own a smartphone. As a Phase 2 trial, this research focuses on measuring the treatment's effectiveness in an initial, smaller group, offering participants a chance to contribute to innovative healthcare solutions.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this digital prosthetic interface technology is safe for dysvascular amputees?
Research shows that digital prosthetic technology is improving, with safety as a key focus. Studies carefully monitor issues like losing balance or getting injured during testing. This ensures that any risks associated with the digital prosthetic are taken seriously and actively managed.
Since this trial is in an early stage, the researchers are still assessing the treatment's safety. Early trials often aim to evaluate how well people can use the new technology. Although specific safety data is not yet available, ensuring the safety of these devices remains a top priority in ongoing research.12345Why do researchers think this study treatment might be promising?
Researchers are excited about the digital prosthetic interface technology for diabetic amputation because it offers a cutting-edge alternative to the traditional socket and liner systems. This new technology from Bionic Skins promises a more personalized and comfortable fit by digitally interfacing with the user's residual limb, potentially enhancing mobility and reducing discomfort. Unlike conventional methods that often require manual adjustments and may lead to skin issues, the digital approach allows for real-time adjustments and improved skin health. This innovation could significantly improve the quality of life for individuals with diabetes who have undergone amputation.
What evidence suggests that this digital prosthetic interface technology is effective for dysvascular amputees?
This trial will compare the effectiveness of digital prosthetic interface technology with traditional socket and liner technology. Research has shown that new digital technology, which participants in this trial may receive, can improve control over prosthetic limbs. This technology enables users to perform multiple actions simultaneously, simplifying the use of the prosthetic limb. Early signs suggest that it could aid individuals who have lost a limb due to diabetes in moving more easily and feeling more comfortable. It combines modern technology with exercises to enhance overall health and limb function for those with circulation-related amputations. Although still under evaluation, the potential benefits for improving quality of life appear promising.13567
Who Is on the Research Team?
Paolo Bonato, PhD
Principal Investigator
Spaulding Rehabilitation Hospital
Are You a Good Fit for This Trial?
This trial is for individuals with a lower limb amputation due to type 2 diabetes complications, who currently use a prosthesis and own a smartphone. They should be able to move at certain levels (K2 or K3) and have had their amputation within the last 4-16 months. People with bilateral amputations, unstable other limbs, conditions preventing exercise, current pregnancy, incompatible body measurements for technology use, or severe limb pain are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Baseline measurements including SEQ, PEQ, and thermal imaging of the residuum are conducted
Treatment
Participants are randomized to either digital prosthetic interface technology or traditional socket-liner technology, combined with an exercise intervention
Follow-up
Participants are monitored for safety and effectiveness after treatment, focusing on step counts and intra-socket interface pressure
What Are the Treatments Tested in This Trial?
Interventions
- Digital Prosthetic Interface Technology
Find a Clinic Near You
Who Is Running the Clinical Trial?
Spaulding Rehabilitation Hospital
Lead Sponsor
Bionic Skins LLC
Collaborator
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator